Capmatinib

• Target:

  C-Met/HGFR|||Apoptosis

• Related Pathways:

  Tyrosine Kinase/Adaptors|||Apoptosis

• Purity:

  0.9976

• Bioactivity:

  Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR) with potential antineoplastic activity.

• Smiles:

  CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1

• Molecular Formula:

  C23H17FN6O

• Molecular Weight:

  412.42

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1029712-80-8